Company: SACH
Filing Date: 2025-11-18
Form Type: 8-K
Source: 0001628280-25-052853
Chunk: 0

Company: Sachem Capital Corp.
Filing Date: 2025-11-18
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

On November 14, 2025, Sachem Capital Corp. (the “ Company”) entered into an At Market Issuance Sales Agreement (the “ Sales Agreement”) with Ladenburg Thalmann & Co. Inc. and Lucid Capital Markets, LLC, as sales agents (collectively, the “ Agents”), pursuant to which the Company may offer and sell, from time to time, through the Agents shares of its 7.75% Series A Cumulative Redeemable Preferred Stock, par value $0.001 per share (the “ Preferred Shares”), in accordance with the terms and conditions set forth in the Sales Agreement.

Sales of Preferred Shares, if any, made under the Sales Agreement will be made by any method permitted by law that is deemed to be an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended (the “ Securities Act”). Under the Sales Agreement, the Company will pay the Agents commissions, discounts or other forms of compensation of up to 2.5% on the sale of Preferred Shares. The Company has no obligation to sell any Preferred Shares under the Sales Agreement.

The offer and sale of the Preferred Shares will be pursuant to a prospectus supplement, dated November 14, 2025 (the “ Prospectus Supplement”), to the Company’s Registration Statement on Form S-3 (File No. 333-287346) (the “ Registration Statement”) declared effective by the Securities and Exchange Commission on May 30, 2025. Under the Prospectus Supplement, up to $18,450,000 of Preferred Shares may be sold from time to time through the Agents.

The Sales Agreement contains customary representations, warranties and agreements of the Company and the Agents, indemnification rights and obligations of the parties, and termination provisions. Under the terms of the Sales Agreement, the Company agreed to indemnify the Agents against certain liabilities, including liabilities under the Securities Act, or to contribute to payments that the Agents may be required to make because of those liabilities.

The foregoing description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is attached to this Current Report on Form 8-K as Exhibit 1.1 and incorporated by reference herein and into the Prospectus Supplement and accompanying base prospectus, which form a part of the Registration Statement.

This Current Report on Form